Adastra Labs Holdings Ltd. (
CSE.XTRX,
OTC: XTXXF,
Forum) – a Health Canada Licensed cannabis company focused on processing, sales, organoleptic and analytical testing – has reported that its wholly owned subsidiary Adastra Labs Inc. achieved a record month of production volume in February,
more than doubling outputs.
Chief Executive Officer and Director of Adastra, Michael Forbes, commented:
"I am extremely proud of our team's commitment and performance which has enabled us to achieve another record production month. With more SKUs launching and co-manufacturing brands coming to market this Spring and Summer, Adastra intends to invest in more processing equipment, along with automation hardware and software to drive costs down and increase production outputs."
Adastra has also announced a recent update to its leadership structure with the departure of Chief Operating Officer, Corporate Secretary and Director, Donald Dinsmore, and the appointment of Michael Forbes as Corporate Secretary.
Details
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.
FULL DISCLOSURE: Adastra Labs Holdings Ltd. is a client of Stockhouse Publishing.